Patents by Inventor Peter Soltesz
Peter Soltesz has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20190388034Abstract: The present invention provides systems, methods, devices and kits for assessing the level of pulmonary disease in individual lung compartments. A lung compartment comprises a subportion of a lung, such as a lobe, a segment or a subsegment, for example. By measuring individual lung compartments, the level of disease of the pulmonary system may be more precisely defined by determining values of disease parameters reflective of individual subportions or compartments of a lung. Likewise, compartments may be separately imaged to provide further measurement information. Once individual compartments are characterized, they may be compared and ranked based on a number of variables reflecting, for example, level of disease or need for treatment. Such comparison may be aided by simultaneous display of such variables or images on a visual display. Further, the same tests may be performed on the lung as a whole or on both lungs and to determine the affect of the diseased lung compartments on the overall lung performance.Type: ApplicationFiled: September 5, 2019Publication date: December 26, 2019Applicant: Pulmonx CorporationInventors: Robert Kotmel, Peter Soltesz, Anthony Wondka, Rodney Perkins
-
Patent number: 10413244Abstract: The present invention provides systems, methods, devices and kits for assessing the level of pulmonary disease in individual lung compartments. A lung compartment comprises a subportion of a lung, such as a lobe, a segment or a subsegment, for example. By measuring individual lung compartments, the level of disease of the pulmonary system may be more precisely defined by determining values of disease parameters reflective of individual subportions or compartments of a lung. Likewise, compartments may be separately imaged to provide further measurement information. Once individual compartments are characterized, they may be compared and ranked based on a number of variables reflecting, for example, level of disease or need for treatment. Such comparison may be aided by simultaneous display of such variables or images on a visual display. Further, the same tests may be performed on the lung as a whole or on both lungs and to determine the affect of the diseased lung compartments on the overall lung performance.Type: GrantFiled: October 21, 2015Date of Patent: September 17, 2019Assignee: Pulmonx CorporationInventors: Robert Kotmel, Peter Soltesz, Anthony Wondka, Rodney Perkins
-
Publication number: 20160249860Abstract: The present invention provides systems, methods, devices and kits for assessing the level of pulmonary disease in individual lung compartments. A lung compartment comprises a subportion of a lung, such as a lobe, a segment or a subsegment, for example. By measuring individual lung compartments, the level of disease of the pulmonary system may be more precisely defined by determining values of disease parameters reflective of individual subportions or compartments of a lung. Likewise, compartments may be separately imaged to provide further measurement information. Once individual compartments are characterized, they may be compared and ranked based on a number of variables reflecting, for example, level of disease or need for treatment. Such comparison may be aided by simultaneous display of such variables or images on a visual display. Further, the same tests may be performed on the lung as a whole or on both lungs and to determine the affect of the diseased lung compartments on the overall lung performance.Type: ApplicationFiled: May 9, 2016Publication date: September 1, 2016Inventors: Robert Kotmel, Peter Soltesz, Anthony Wondka, Rodney Perkins
-
Publication number: 20160038058Abstract: The present invention provides systems, methods, devices and kits for assessing the level of pulmonary disease in individual lung compartments. A lung compartment comprises a subportion of a lung, such as a lobe, a segment or a subsegment, for example. By measuring individual lung compartments, the level of disease of the pulmonary system may be more precisely defined by determining values of disease parameters reflective of individual subportions or compartments of a lung. Likewise, compartments may be separately imaged to provide further measurement information. Once individual compartments are characterized, they may be compared and ranked based on a number of variables reflecting, for example, level of disease or need for treatment. Such comparison may be aided by simultaneous display of such variables or images on a visual display. Further, the same tests may be performed on the lung as a whole or on both lungs and to determine the affect of the diseased lung compartments on the overall lung performance.Type: ApplicationFiled: October 21, 2015Publication date: February 11, 2016Inventors: Robert Kotmel, Peter Soltesz, Anthony Wondka, Rodney Perkins
-
Patent number: 8876791Abstract: A method and system for increasing the flow resistance of collateral pathways in the lung by employing aspiration to establish an artificial convective flow current between compartments in the lung in order to entrain and deliver a clogging agent preferentially to the collateral pathways. The method may sometimes be performed after lung has been assessed for the presence of collateral pathways.Type: GrantFiled: September 15, 2010Date of Patent: November 4, 2014Assignee: Pulmonx CorporationInventors: Anthony Wondka, Peter Soltesz, John McCutcheon, Antony J. Fields
-
Publication number: 20130245484Abstract: Minimally invasive methods, systems and devices are provided for qualitatively and quantitatively assessing collateral ventilation in the lungs. In particular, collateral ventilation of a target compartment within a lung of a patient is assessed by advancement of a catheter through the tracheobronchial tree to a feeding bronchus of the target compartment. The feeding bronchus is occluded by the catheter and a variety of measurements are taken with the use of the catheter in a manner which is of low risk to the patient. Examples of such measurements include but are not limited to flow rate, volume and pressure. These measurements are used to determine the presence of collateral ventilation and to quantify such collateral ventilation.Type: ApplicationFiled: May 10, 2013Publication date: September 19, 2013Applicant: Pulmonx CorporationInventors: Nikolai Aljuri, Anthony Wondka, George Surjan, Kirk Davis, Peter Soltesz, Rodney C. Perkins
-
Patent number: 8454527Abstract: Minimally invasive methods, systems and devices are provided for qualitatively and quantitatively assessing collateral ventilation in the lungs. In particular, collateral ventilation of a target compartment within a lung of a patient is assessed by advancement of a catheter through the tracheobronchial tree to a feeding bronchus of the target compartment. The feeding bronchus is occluded by the catheter and a variety of measurements are taken with the use of the catheter in a manner which is of low risk to the patient. Examples of such measurements include but are not limited to flow rate, volume and pressure. These measurements are used to determine the presence of collateral ventilation and to quantify such collateral ventilation.Type: GrantFiled: December 17, 2010Date of Patent: June 4, 2013Assignee: Pulmonx CorporationInventors: Nikolai Aljuri, Anthony Wondka, George Surjan, Kirk Davis, Peter Soltesz, Rodney C. Perkins
-
Publication number: 20110220104Abstract: A method and system for increasing the flow resistance of collateral pathways in the lung by employing aspiration to establish an artificial convective flow current between compartments in the lung in order to entrain and deliver a clogging agent preferentially to the collateral pathways. The method may sometimes be performed after lung has been assessed for the presence of collateral pathways.Type: ApplicationFiled: September 15, 2010Publication date: September 15, 2011Applicant: Pulmonx CorporationInventors: Anthony Wondka, Peter Soltesz, John McCutcheon, Antony J. Fields
-
Publication number: 20110087122Abstract: Minimally invasive methods, systems and devices are provided for qualitatively and quantitatively assessing collateral ventilation in the lungs. In particular, collateral ventilation of a target compartment within a lung of a patient is assessed by advancement of a catheter through the tracheobronchial tree to a feeding bronchus of the target compartment. The feeding bronchus is occluded by the catheter and a variety of measurements are taken with the use of the catheter in a manner which is of low risk to the patient. Examples of such measurements include but are not limited to flow rate, volume and pressure. These measurements are used to determine the presence of collateral ventilation and to quantify such collateral ventilation.Type: ApplicationFiled: December 17, 2010Publication date: April 14, 2011Applicant: Pulmonx CorporationInventors: Nikolai Aljuri, Anthony Wondka, George Surjan, Kirk Davis, Peter Soltesz, Rodney C. Perkins
-
Patent number: 7883471Abstract: Minimally invasive methods, systems and devices are provided for qualitatively and quantitatively assessing collateral ventilation in the lungs. In particular, collateral ventilation of a target compartment within a lung of a patient is assessed by advancement of a catheter through the tracheobronchial tree to a feeding bronchus of the target compartment. The feeding bronchus is occluded by the catheter and a variety of measurements are taken with the use of the catheter in a manner which is of low risk to the patient. Examples of such measurements include but are not limited to flow rate, volume and pressure. These measurements are used to determine the presence of collateral ventilation and to quantify such collateral ventilation.Type: GrantFiled: December 7, 2005Date of Patent: February 8, 2011Assignee: Pulmonx CorporationInventors: Nikolai Aljuri, Anthony Wondka, George Surjan, Kirk Davis, Peter Soltesz, Rodney C. Perkins
-
Patent number: 7458963Abstract: Lung volume reduction is performed in a minimally invasive manner by isolating a lung tissue segment, optionally reducing gas flow obstructions within the segment, and aspirating the segment to cause the segment to at least partially collapse. Further optionally, external pressure may be applied on the segment to assist in complete collapse. Reduction of gas flow obstructions may be achieved in a variety of ways, including over inflation of the lung, introduction of mucolytic or dilation agents, application of vibrational energy, induction of absorption atelectasis, or the like. Optionally, diagnostic procedures on the isolated lung segment may be performed, typically using the same isolation/access catheter.Type: GrantFiled: August 20, 2004Date of Patent: December 2, 2008Assignee: PULMONxInventors: Rodney C. Perkins, Peter Soltesz, Robert Kotmel
-
Publication number: 20080200797Abstract: The present invention provides systems, methods, devices and kits for assessing the level of pulmonary disease in individual lung compartments. A lung compartment comprises a subportion of a lung, such as a lobe, a segment or a subsegment, for example. By measuring individual lung compartments, the level of disease of the pulmonary system may be more precisely defined by determining values of disease parameters reflective of individual subportions or compartments of a lung. Likewise, compartments may be separately imaged to provide further measurement information. Once individual compartments are characterized, they may be compared and ranked based on a number of variables reflecting, for example, level of disease or need for treatment. Such comparison may be aided by simultaneous display of such variables or images on a visual display. Further, the same tests may be performed on the lung as a whole or on both lungs and to determine the affect of the diseased lung compartments on the overall lung performance.Type: ApplicationFiled: April 23, 2008Publication date: August 21, 2008Applicant: PULMONxInventors: Robert Kotmel, Peter Soltesz, Anthony Wondka, Rodney Perkins
-
Publication number: 20070186932Abstract: A method and system for increasing the flow resistance of pathways in the lung by employing aspiration to establish an artificial convective flow current between compartments in the lung in order to entrain and deliver a clogging agent preferentially to the pathways. This treatment is performed after an area has been properly diagnosed for treatment.Type: ApplicationFiled: January 4, 2007Publication date: August 16, 2007Applicant: PULMONxInventors: Anthony Wondka, Peter Soltesz
-
Publication number: 20070043350Abstract: Medical methods and systems are provided for effecting lung volume reduction by selectively ablating segments of lung tissue.Type: ApplicationFiled: July 28, 2006Publication date: February 22, 2007Applicant: PULMONxInventors: Peter Soltesz, Nikolai Aljuri, Ajit Nair
-
Publication number: 20060264772Abstract: Minimally invasive methods, systems and devices are provided for qualitatively and quantitatively assessing collateral ventilation in the lungs. In particular, collateral ventilation of a target compartment within a lung of a patient is assessed by advancement of a catheter through the tracheobronchial tree to a feeding bronchus of the target compartment. The feeding bronchus is occluded by the catheter and a variety of measurements are taken with the use of the catheter in a manner which is of low risk to the patient. Examples of such measurements include but are not limited to flow rate, volume and pressure. These measurements are used to determine the presence of collateral ventilation and to quantify such collateral ventilation.Type: ApplicationFiled: December 7, 2005Publication date: November 23, 2006Applicant: PULMONXInventors: Nikolai Aljuri, Anthony Wondka, George Surjan, Kirk Davis, Peter Soltesz, Rodney Perkins
-
Publication number: 20060162731Abstract: Methods, systems and devices are provided for performing lung volume reduction in patients suffering from chronic obstructive pulmonary disease or other conditions where isolation of a lung segment or reduction of lung volume is desired. The methods are minimally invasive with instruments being introduced through the mouth (endotracheally) and rely on isolating the target lung tissue segment from other regions of the lung and occluding various lung passageways with the use of occlusal stents. The occlusal stents are delivered with the use of an occlusal stent delivery system which is loaded with the occlusal stent with the use of an occlusal stent loading system.Type: ApplicationFiled: November 15, 2005Publication date: July 27, 2006Applicant: PULMONxInventors: Anthony Wondka, Peter Soltesz, Robert Kotmel, Nadia Matov, Thomas Crowder
-
Publication number: 20060135947Abstract: Improved methods, systems and devices for occluding body passageways, particularly lung passageways. Such occlusion is achieved with occlusal stents which are particularly suited for use in performing Endobronchial Volume Reduction (EVR) in patients suffering from chronic obstructive pulmonary disease or other conditions where isolation of a lung segment or reduction of lung volume is desired. The present invention is likewise suitable for the treatment of bronchopleural fistula and potentially for other pulmonary diseases, such as hemoptysis and pneumothorax. The occlusal stents are delivered with the use of any suitable delivery system, particularly minimally invasive with instruments introduced through the mouth (endotracheally). A target lung tissue segment is isolated from other regions of the lung by deploying an occlusal stent into a target area of a lung passageway. A variety of different occlusal stent designs are provided to improve the performance and reliability of the delivered occlusal stent.Type: ApplicationFiled: November 15, 2005Publication date: June 22, 2006Applicant: PULMONxInventors: Peter Soltesz, Anthony Wondka, Jeffrey Lee, Robert Kotmel
-
Publication number: 20060095002Abstract: The present invention provides improved methods, systems, devices and kits for performing lung volume reduction in patients suffering from chronic obstructive pulmonary disease or other conditions where isolation of a lung segment or reduction of lung volume is desired. The methods are minimally invasive with instruments being introduced through the mouth (endotracheally) and rely on isolating the target lung tissue segment from other regions of the lung. Isolation is achieved by deploying an obstructive device in a lung passageway leading to the target lung tissue segment. Once the obstructive device is anchored in place, the segment can be aspirated through the device. This may be achieved by a number of methods, including coupling an aspiration catheter to an inlet port on the obstruction device and aspirating through the port.Type: ApplicationFiled: November 9, 2005Publication date: May 4, 2006Applicant: PULMONxInventors: Peter Soltesz, Robert Kotmel, Tony Wondka, Michael Reilly, Wally Buch
-
Publication number: 20050203483Abstract: Lung volume reduction is performed in a minimally invasive manner by isolating a lung tissue segment, optionally reducing gas flow obstructions within the segment, and aspirating the segment to cause the segment to at least partially collapse. Further optionally, external pressure may be applied on the segment to assist in complete collapse. Reduction of gas flow obstructions may be achieved in a variety of ways, including over inflation of the lung, introduction of mucolytic or dilation agents, application of vibrational energy, induction of absorption atelectasis, or the like. Optionally, diagnostic procedures on the isolated lung segment may be performed, typically using the same isolation/access catheter.Type: ApplicationFiled: April 12, 2005Publication date: September 15, 2005Applicant: PULMONxInventors: Rodney Perkins, Peter Soltesz, Robert Kotmel, Anthony Wondka
-
Publication number: 20050015106Abstract: Lung volume reduction is performed in a minimally invasive manner by isolating a lung tissue segment, optionally reducing gas flow obstructions within the segment, and aspirating the segment to cause the segment to at least partially collapse. Further optionally, external pressure may be applied on the segment to assist in complete collapse. Reduction of gas flow obstructions may be achieved in a variety of ways, including over inflation of the lung, introduction of mucolytic or dilation agents, application of vibrational energy, induction of absorption atelectasis, or the like. Optionally, diagnostic procedures on the isolated lung segment may be performed, typically using the same isolation/access catheter.Type: ApplicationFiled: August 20, 2004Publication date: January 20, 2005Applicant: PULMONxInventors: Rodney Perkins, Peter Soltesz, Robert Kotmel